PUBLIC COMPANY
saveSimcere Pharmaceutical Group Ltd
updated 4mo ago
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines.
community read0 votes
pipeline
6
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(6)
pipeline depth6 products
5Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Roche finds another oncology gem in Asia with $1.5B B cell disease partnershipRoche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.biospace · 1mo ago
- Roche inks $1.53B deal for Simcere’s B-cell-targeting antibodyRoche is paying oncology-focused Simcere Zaiming $75 million upfront for global rights to a preclinical trispecific antibody targeting B-cell-mediated diseases.fiercebiotech · 1mo ago
comments(0)
5-min edit window · permanent after that